OrthoPediatrics Management

Management criteria checks 2/4

OrthoPediatrics' CEO is David Bailey, appointed in Jun 2020, has a tenure of 3.83 years. total yearly compensation is $2.72M, comprised of 18.4% salary and 81.6% bonuses, including company stock and options. directly owns 0.59% of the company’s shares, worth €3.94M. The average tenure of the management team and the board of directors is 3.5 years and 12.3 years respectively.

Key information

David Bailey

Chief executive officer

US$2.7m

Total compensation

CEO salary percentage18.4%
CEO tenure3.8yrs
CEO ownership0.6%
Management average tenure3.5yrs
Board average tenure12.3yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has David Bailey's remuneration changed compared to OrthoPediatrics's earnings?
DateTotal CompensationSalaryCompany Earnings
Dec 31 2023US$3mUS$500k

-US$21m

Sep 30 2023n/an/a

-US$22m

Jun 30 2023n/an/a

US$976k

Mar 31 2023n/an/a

US$4m

Dec 31 2022US$1mUS$415k

US$1m

Sep 30 2022n/an/a

US$9m

Jun 30 2022n/an/a

-US$12m

Mar 31 2022n/an/a

-US$15m

Dec 31 2021US$906kUS$371k

-US$16m

Sep 30 2021n/an/a

-US$30m

Jun 30 2021n/an/a

-US$33m

Mar 31 2021n/an/a

-US$38m

Dec 31 2020US$898kUS$371k

-US$33m

Sep 30 2020n/an/a

-US$23m

Jun 30 2020n/an/a

-US$22m

Mar 31 2020n/an/a

-US$15m

Dec 31 2019US$836kUS$300k

-US$13m

Sep 30 2019n/an/a

-US$11m

Jun 30 2019n/an/a

-US$10m

Mar 31 2019n/an/a

-US$10m

Dec 31 2018US$590kUS$266k

-US$12m

Sep 30 2018n/an/a

-US$25m

Jun 30 2018n/an/a

-US$26m

Mar 31 2018n/an/a

-US$26m

Dec 31 2017US$483kUS$258k

-US$24m

Compensation vs Market: David's total compensation ($USD2.72M) is above average for companies of similar size in the German market ($USD1.29M).

Compensation vs Earnings: David's compensation has increased whilst the company is unprofitable.


CEO

David Bailey (44 yo)

3.8yrs

Tenure

US$2,721,840

Compensation

Mr. David R. Bailey serves as the Chief Executive Officer at OrthoPediatrics Corp. since June 01, 2021. He serves as the President at OrthoPediatrics Corp. since June 3, 2020 and serves as its Director sin...


Leadership Team

NamePositionTenureCompensationOwnership
Mark Throdahl
Executive Chairman15.3yrsno data0.67%
$ 4.5m
David Bailey
President3.8yrsUS$2.72m0.59%
$ 3.9m
Fred Hite
CFO, Principal Financial & Accounting Officer9.2yrsUS$2.04m0.40%
$ 2.7m
Daniel Gerritzen
Executive VP of Legal15.3yrsUS$1.35m0.22%
$ 1.5m
Gregory Odle
President of Scoliosisno dataUS$1.35m0.34%
$ 2.3m
Kevin Unger
President of Enabling Technologiesless than a yearUS$22.50kno data
Joseph Hauser
President of Trauma & Deformity Correction3.3yrsUS$1.35m0.22%
$ 1.5m
Joel Batts
Senior Vice President of Clinical & Regulatory Affairs1.5yrsno datano data
Mark Karshner
Senior Vice President of International Sales8.3yrsno datano data

3.5yrs

Average Tenure

53yo

Average Age

Experienced Management: 2X7's management team is considered experienced (3.5 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Mark Throdahl
Executive Chairman15.3yrsno data0.67%
$ 4.5m
David Bailey
President2.4yrsUS$2.72m0.59%
$ 3.9m
Fred Hite
CFO, Principal Financial & Accounting Officer8.7yrsUS$2.04m0.40%
$ 2.7m
Terry Schlotterback
Lead Independent Director15.3yrsUS$185.00k0.076%
$ 509.1k
Peter Armstrong
Chair of Surgeon Advisory Boardno datano datano data
David Pelizzon
Director13.3yrsUS$180.00k0.092%
$ 616.1k
Bryan Hughes
Independent Director12.3yrsUS$190.00k0.042%
$ 284.5k
Henry Chambers
Member of Surgeon Advisory Boardno datano datano data
J. Gordon
Member of Surgeon Advisory Boardno datano datano data
H. Graham
Member of Surgeon Advisory Boardno datano datano data
Daniel Hoernschemeyer
Member of Surgeon Advisory Boardno datano datano data
Marie Infante
Independent Director10.3yrsUS$185.00k0.036%
$ 243.2k

12.3yrs

Average Tenure

67yo

Average Age

Experienced Board: 2X7's board of directors are seasoned and experienced ( 12.3 years average tenure).


Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.